DOCSLIB.ORG

Abstract Book

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Abstract Book AEPROMO, 2012 Revista Española de Ozonoterapia Vol.2 No. 2. Supplement 1, 2012, ISSN 2174‐3215 III International Congress of AEPROMO "The ozonetherapy in the medical agenda" Spanish Association of Medical Professionals in Ozone Therapy III International Congress of AEPROMO 7th -9th June, 2012. Complutense University of Madrid, Spain. Abstract Book Abstract Book 7th - 9th June, 2012. Complutense University of Madrid, Spain. Organizer: Spanish Association of Medical Professionals in Ozone Therapy (AEPROMO) Page 1 of 117 AEPROMO, 2012 Revista Española de Ozonoterapia Vol.2 No. 2. Supplement 1, 2012, ISSN 2174‐3215 III International Congress of AEPROMO "The ozonetherapy in the medical agenda" Spanish Association of Medical Professionals in Ozone Therapy Index Scientific Committee ......................................................................................................................................................................... 4 Organizing committee....................................................................................................................................................................... 4 Sponsors........................................................................................................................................................................................... 5 Preface.............................................................................................................................................................................................. 8 Conference Agenda Pre-congress workshop ................................................................................................................................. 12 Conference Agenda........................................................................................................................................................................ 13 Conference Agenda - Agenda Congreso (English/Español)........................................................................................................... 15 Plenary lecture index ...................................................................................................................................................................... 22 Antiatherogenic Effects of Ozone Therapy in an Experimental Model of Atherosclerosis. ........................................................ 24 Effects of Ozone Therapy on Haemostatic and Oxidative Stress Index in Coronary Artery Disease. ....................................... 26 Is Therapeutic Ozone Genotoxic?.............................................................................................................................................. 27 Efficiency of Ozonotherapy in Psychological Variables in the Fibromyalgia Treatment: A Pilot Study...................................... 29 The Contributions of Ozone Therapy to Parkinson’s Disease. .................................................................................................. 31 Effect of Ozone Therapy in Treating Toxoplasmosis in Cases with Recurrent Abortion (A Comparative Study). ..................... 33 Combined Technique of Ozontherapy and Platelet Derived Growth Factors in the Knee Osteoarthritis................................... 34 The Mechanism of Action of Ozonetherapy at a Molecular Level.............................................................................................. 36 Treatment of Disk and Degenerative Pathologies of the Spine with Plasma Rich in Growth Platelet Inhibitors Factors........... 37 Ozone in Oncology. Clinical Experience and Research Areas at the Dr. Negrin University Hospital........................................ 39 The Effects of Ozone Therapy in Conjunction with Vaccination Immunotherapy for Malignant Brain Tumor: Case Study. ...... 41 Ozone-Oxygen Injectionsin Acupuncture Points: A New Approach........................................................................................... 42 Use of Ozone and Ozonized Growth Factors in Dogs. Clinical Cases. ..................................................................................... 44 Head and Neck Pain.Therapeutic Role of Ozonetherapy. ......................................................................................................... 46 Individualization of Infusion Therapy with Oxygen Reactive Forms........................................................................................... 47 Clinical Experience in the Treatment of Epidemic Hemorrhagic Conjunctivitis with Oleozon® Collyrium................................... 48 Ozone Therapy for Viral Hepatitis.What Can be Expected?...................................................................................................... 50 The Low-Dose Ozone Concept: Signal Transduction and Bioregulation Through “Ozone Peroxides” as Second Messenger Molecules................................................................................................................................................................................... 51 Changes in Arterial Stiffness-Distensibility and Cardiovascular Risk Factors (Franingham) after Major Autohemotherapy with Oxygen-Ozone........................................................................................................................................................................... 52 Treatment for Radicular Compression.Experience of 492 Cases in Bolivia............................................................................... 53 Sepsis and Ozone Therapy in ICU / Clinical Study and two Case Reports. .............................................................................. 55 Ozone Applications in Spine Diseases. ..................................................................................................................................... 56 Ozone Therapy in Degenerative Disc Disease. ......................................................................................................................... 57 Ozonetherapy Challenges Facing the Legislation...................................................................................................................... 58 Perspectives of Ozone Containing External Preparations Using in Dermatology...................................................................... 60 Results of Conservative Treatment of Tarsal Tunnel Syndrome: Medical Ozone Infiltration and Surgery. ............................... 61 Ozone Therapy in Urology. ........................................................................................................................................................ 63 Combined Therapy Ultraviolet Irradiation of Autologus Blood Plus Ozone................................................................................ 65 Ozonetherapy in Multiple Sclerosis. Case Report...................................................................................................................... 66 Ozone Therapy in Recurrent Vulvovaginal Candida albicans Infections. .................................................................................. 68 Treatment of Symptomatic Spinal Degenerative Pathologies by Means of Combined Conservative Biochemical Treatments.69 Abstract Book 7th - 9th June, 2012. Complutense University of Madrid, Spain. Organizer: Spanish Association of Medical Professionals in Ozone Therapy (AEPROMO) Page 2 of 117 AEPROMO, 2012 Revista Española de Ozonoterapia Vol.2 No. 2. Supplement 1, 2012, ISSN 2174‐3215 III International Congress of AEPROMO "The ozonetherapy in the medical agenda" Spanish Association of Medical Professionals in Ozone Therapy Poster.............................................................................................................................................................................................. 70 Ozone Therapy and Epidermal Growth Factors: A New Approach in the Treatment of the Diabetic Foot. ............................... 70 Technologies of ozone therapy in military medicine. ................................................................................................................. 71 Ozone Therapy in Complex Treatment of Cattle Malignant Edema........................................................................................... 72 Estimation of Physical and Chemical Factors Effect on Human Blood Serum Self-Organization.............................................. 73 Spondylodiscitis Treated by Ozone Therapy. Experience of 15 cases...................................................................................... 74 Morphological Effects of Ozone or Ozonized Oil on Rectal Mucosa of Rats. ............................................................................ 76 Treatment of Anorectal Fistulas with Ozone. ............................................................................................................................. 77 Ozone Therapy and Epidermal Growth Factors: A New Approach in the Treatment of the Diabetic Foot. ............................... 78 Workshops...................................................................................................................................................................................... 80 Discólisis: Práctica en Cadáveres y Simuladores. Infiltraciones Con Ozono en Clínica del Dolor. ........................................... 81 SpeakersCV...................................................................................................................................................................................
Load more

Recommended publications
  • Venezuela Economic Collapse Creates Family Planning Crisis President’S Note
    Volume 50, Issue 4 December 2018 VENEZUELA ECONOMIC COLLAPSE CREATES FAMILY PLANNING CRISIS President’s Note “Half the truth is often a great lie.” – Benjamin Franklin y failing even to mention population growth in the What will they tell hundreds of millions fated to become state- thirty-three-page “Summary for Policymakers” of less environmental refugees, pushed to relocate due to climate its new publication, Global Warming of 1.5°C, the change? What will they say to subsistence farmers forced to BIntergovernmental Panel on Climate Change (IPCC) offered watch their families starve as meager plots become arid waste- less than the whole truth. This is despite the fact that a 2010 lands? And what about the countless, voiceless species doomed paper published in the Proceedings of the National Academy to extinction because so many authorities tremble at the very of Sciences concluded that by the end of the century, slower possibility of a negative reaction? population growth could reduce total fossil fuel emissions by 37–41 percent. Benjamin Franklin, the redoubtable author of Poor Richard’s Almanack, warns, “You may delay, but time will not.” The IPCC “Summary for Policymakers” finds room to call for ecosystem-based adaptation, ecosystem restoration, biodiversity There is no excuse for timid temporizing in the face of a global management, sustainable aquaculture, efficient irrigation, social crisis. When climate experts fail to address population growth safety nets, disaster risk management, green infrastructure, sus- — arguably the single biggest driver of climate change — they tainable land use, and water management. But not one single place far more than their own reputations at risk.
    [Show full text]
  • Index to the NLM Classification 2011
    National Library of Medicine Classification 2011 Index Disease see Tyrosinemias 1-8 5,12-diHETE see Leukotriene B4 1,2-Benzopyrones see Coumarins 5,12-HETE see Leukotriene B4 1,2-Dibromoethane see Ethylene Dibromide 5-HT see Serotonin 1,8-Dihydroxy-9-anthrone see Anthralin 5-HT Antagonists see Serotonin Antagonists 1-Oxacephalosporin see Moxalactam 5-Hydroxytryptamine see Serotonin 1-Propanol 5-Hydroxytryptamine Antagonists see Serotonin Organic chemistry QD 305.A4 Antagonists Pharmacology QV 82 6-Mercaptopurine QV 269 1-Sar-8-Ala Angiotensin II see Saralasin 7S RNA see RNA, Small Nuclear 1-Sarcosine-8-Alanine Angiotensin II see Saralasin 8-Hydroxyquinoline see Oxyquinoline 13-cis-Retinoic Acid see Isotretinoin 8-Methoxypsoralen see Methoxsalen 15th Century History see History, 15th Century 8-Quinolinol see Oxyquinoline 16th Century History see History, 16th Century 17 beta-Estradiol see Estradiol 17-Ketosteroids WK 755 A 17-Oxosteroids see 17-Ketosteroids A Fibers see Nerve Fibers, Myelinated 17th Century History see History, 17th Century Aardvarks see Xenarthra 18th Century History see History, 18th Century Abate see Temefos 19th Century History see History, 19th Century Abattoirs WA 707 2',3'-Cyclic-Nucleotide Phosphodiesterases QU 136 Abbreviations 2,4-D see 2,4-Dichlorophenoxyacetic Acid Chemistry QD 7 2,4-Dichlorophenoxyacetic Acid General P 365-365.5 Organic chemistry QD 341.A2 Library symbols (U.S.) Z 881 2',5'-Oligoadenylate Polymerase see Medical W 13 2',5'-Oligoadenylate Synthetase By specialties (Form number 13 in any NLM
    [Show full text]
  • Abstract Book 10Th -12Th November, 2011 Hotel Great Parnasuss, Cancun, Mexico
    AMOZON, 2011 Revista Española de Ozonoterapia Vol.2 Supplement 1 2012, ISSN 2174-3215 II International Medical Ozone Federation Congress. IMEOF III Mexican Ozonetherapy Association Congress. AMOZON "For the Integration of Ozonetherapy into the Conventional Medicine” II International Medical Ozone Federation Congress. IMEOF III Mexican Ozonetherapy Association Congress. AMOZON "For the Integration of Ozonetherapy into the Conventional Medicine” AAbbssttrraacctt BBooookk Abstract Book 10th -12th November, 2011 Hotel Great Parnasuss, Cancun, Mexico Organizer: Mexican Ozonetherapy Association (AMOZON) Page 1 of 121 AMOZON, 2011 Revista Española de Ozonoterapia Vol.2 Supplement 1 2012, ISSN 2174-3215 II International Medical Ozone Federation Congress. IMEOF III Mexican Ozonetherapy Association Congress. AMOZON "For the Integration of Ozonetherapy into the Conventional Medicine” Index Scientific committee ....................................................................................................................................................... 4 Organizing committee .................................................................................................................................................... 4 Sponsors ........................................................................................................................................................................ 5 Preface ..........................................................................................................................................................................
    [Show full text]
  • OUTLINE of PUBLIC HEALTH in VENEZUELA by Dr
    OUTLINE OF PUBLIC HEALTH IN VENEZUELA By Dr. M. LARES GABALDÓN Chief of the Service of Injormation and Health Education, of the Ministry of Realth and Social Weljare Venezuelan public health organisation had its beginning March 17, 1909, with the creation of the Public Health Commission. In November, 1911, the National Office of Health mas inaugurated, with its Institute of Hygiene and its Chemistry, Bacteriology, and Parasitology Laboratories. In 1926 the first venereal disease dispensary was opened, in Caracas, and a Sanitary Engineering Commission was appointed. The first tuberculosis dispensary was opened in 1928. In 1929 the National Health Office incressed its activities, with the creation of laboratories for water analysis, physiotherapy, and radium therapy (this last constituting the beginning of the campaign against cancer). At this same time the studies of malaria and hookworm were carried forward, with the collaboration of the Rockefeller Foundation; the School Inspection Service was organized, anda “National Sanitary Conference” was set up to study national public health problems. With the establishment of the Ministry of Public Health, Agriculture and Husbandry, in August, 1930 a transformation of Venezuelan public health organi- zation was begun, which was intensified with the creation in 1936 of two new Ministries: that of Public Health and Social Welfare, and that of Agriculture and Husbandry. Since then sanitary services have multiplied rapidly, with the opening of tuberculosis, venereal disease and maternal and Child welfare dis- pensaries and clin&, under their respective Diviaions of the Ministry. In 1936 the Divisions of Yellow Fever Prevention and of Malaria were created, the latter having an annual budget of 3,000,OOObolivares.
    [Show full text]
  • Abstract Book
    AEPROMO, 2017 Revista Española de Ozonoterapia Vol.7 No. 2. Supplement 1, 2017, ISSN 2174-3215 V International Congress of AEPROMO. VI International Congress of IMEOF “Better Ozone Therapy with Training, Investigation and Publication” Spanish Association of Medical Professionals in Ozone Therapy V International Congress of AEPROMO VI International Congress of IMEOF 1th -3th June, 2017. School of Medicine. Complutense University, Moncloa Campus, Madrid, Spain. Abstract Book Abstract Book 1th - 3th June, 2017. School of Medicine, Complutense University, Madrid, Spain. Organizer: Spanish Association of Medical Professionals in Ozone Therapy (AEPROMO) Page 1 of 96 AEPROMO, 2017 Revista Española de Ozonoterapia Vol.7 No. 2. Supplement 1, 2017, ISSN 2174-3215 V International Congress of AEPROMO. VI International Congress of IMEOF “Better Ozone Therapy with Training, Investigation and Publication” Spanish Association of Medical Professionals in Ozone Therapy Index Scientific Committee ............................................................................................................................................................................. 4 Organizing committee ........................................................................................................................................................................... 4 Sponsors ................................................................................................................................................................................................
    [Show full text]
  • MEDICAL DEVICES: MANAGING the Mismatch an Outcomeoftheprioritymedicaldevicesproject
    MEDICAL DEVICES: MANAGING THE MEDICAL DEVICES: Mismatch An outcomeofthePriorityMedicalDevicesproject MEDICAL DEVICES: MANAGING THE Mismatch An outcome of the Priority Medical Devices project Department of Essential Health Technologies World Health Organization 20 Avenue Appia CH-1211 Geneva 27 Switzerland Tel: +41 22 791 3648 E-mail: [email protected] 9 789241 564045 Medical devices: managing the Mismatch An outcome of the Priority Medical Devices project WHO Library Cataloguing-in-Publication Data Medical devices: managing the mismatch: an outcome of the priority medical devices project. 1.Equipment and supplies - standards. 2.Cost of illness. 3.Biomedical engineering. 4.Research. 5.Appropriate technology. I.World Health Organization. ISBN 978 92 4 156404 5 (NLM classification: WX 147) © World Health Organization 2010 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
    [Show full text]
  • Venezuela: Health Emergency
    12-month update Venezuela: Health Emergency Emergency appeal no° MDRVE004 Timeframe covered by this update: 27 January 2019 to 27 April 2020 Date of issue: 23 May 2020 Operation timeframe: 18 months Operation start date: 27 January 2019 (DREF Operation End date: 27 July 2021 (Extended 12 operation) with Emergency Appeal start date: 8 April months with this update) 2019 Overall operation budget: 50 million Swiss francs DREF amount allocated: 1 million Swiss francs N° of people being assisted: 650,000 people Red Cross Red Crescent Movement partners currently actively involved in the operation: The Venezuelan Red Cross (VRC) has approximately 4,000 volunteers, 24 branches and 11 subcommittees. In addition, it has 8 hospitals, 34 outpatient clinics and approximately 1,400 employees. Other partner organizations actively involved in the operation: United Nations Office for the Coordination of Humanitarian Affairs (OCHA), United Nations Children's Fund (UNICEF), Pan American Health Organization (PAHO/WHO), Ministry of People's Power for Health (MPPS) and the Ministry of Foreign Affairs. Summary of major revisions This 12-month update reports on the integrated actions that the Venezuelan Red Cross, with IFRC support, has implemented during the first year of the operation. This operation has been closely linked to complement programmatic actions in Venezuela. During this reporting period, the coordinated efforts of VRC volunteers and staff with the IFRC team in country and through the Americas Regional Office have reached 164,606 people with health services; 81,005 people with water, sanitation and hygiene (WASH) actions. The VRC has mobilized 3,617 volunteers and staff to contribute to the operation’s objectives, as well as receive training and other support to enhance their actions and ensure their safety.
    [Show full text]
  • 2020 Declaración-De-Madrid EN-7.Pdf
    MADRID DECLARATION ON OZONE THERAPY (3rd edition) Official document of ISCO3 EDITION No. 01 ISSUE DATE: June 4th, 2010 EDITION No. 02 ISSUE DATE: June 12th, 2015 EDITION No. 03 ISSUE DATE: May 14th, 2020 Copyright (©) 2010, 2015, 2020. ISCO3 (International Scientific Committee of Ozone Therapy) Avenida Juan Andrés 60, local 1 bajo, 28035, Madrid (Spain). All rights reserved. www.isco3.org [email protected] Tel. + 34 91 351 51 75 / +34 669 685 429 ISBN: 978-84-09-19932-7 Statutory Deposit: M-11427-2020 Original language: English. Reviewers: Adriana Schwartz, M.D. Gregorio Martínez Sánchez, Pharm. Dr., Ph.D. Cum Laude. Roberto Quintero, Lawyer Revision of English style: Wayne McCarthy and other members of ISCO3. The only official version of the Madrid Declaration on Ozone Therapy (ISCO3, 3rd edition, 2020) is published in English. Graphic design: Clara Barrachina. Secretarial support: Olga Moreno. Layout and printed by Grafox Imprenta, S.L. (Spain). International Scientific Committee of Ozone Therapy (3rd ed., 2020) “For the Unification of Criteria in the Practice of Ozone Therapy” Official document of ISCO3 1st edition: Approved at the “International Meeting of Ozone Therapy Schools” held at the Royal National Academy of Medicine in Madrid on June 4th, 2010, under the auspices of AEPROMO (Spanish Association of Medical Professionals in Ozone Therapy). 2nd edition with updates and addendum on Dentistry: Approved by ISCO3 on May 10th, 2015 and officially presented at the “International Meeting of the Madrid Declaration on Ozone Therapy (2nd ed.)” held at the Spanish Royal National Academy of Medicine in Madrid on June 12th, 2015, under the auspices of ISCO3 (International Scientific Committee of Ozone Therapy) and the administrative and logistical support of AEPROMO (Spanish Association of Medical Professionals in Ozone Therapy).
    [Show full text]
  • Alberto Alexandre Editor INTRODUCTION
    THE USE OF OZONE IN SPINAL DEGENERATIVE PATHOLOGIES Alberto Alexandre Editor INTRODUCTION Ozone is a very important gas in the stratosphere, reaching its maximum concentration (1000μg/m3above) at a height of 20-30km. Is an unstable gas. It is composed of three atoms of oxygen and has a high breakdown rate ranging in the order of 105-106mol/s. Ozone is 1.6 times denser and 10 times more soluble in water (49.0mLin 100mL of water at 0°C) than oxygen and even though ozone is not a radical molecule, it is the third most powerful oxidant after fluorine and perisulfate. Ozone is produced by three main sources of energy: chemical electrolysis, electrical shock, and UV radiation. Ozone-theraphy has been used for therapeutic purposes since the late XVII century, in different therapeutic modalities with unexpected results in some pathologies. In the scientific literature the first mention of ozone was by the Dutch physicist Van Marumom Mak in 1785. During experiments with a powerful facility for electrification he discovered that in the air around the “ Large lectic Machine” there was a gaseous substance with characteristic smell, which had strong oxidizing properties. In 1840 the professor of the University of Basel Christian Frederick Schonbein related the changes in the properties of oxygen with the formation of a particular gas which he called ozone (from the Greek word ozein “smelly”). Schonbein first detected ozone capacity to merge with biological substrates at positions corresponding to the double bonds. The German chemist Christian Friedrich Schonbein, is also known for the discovery of nitrocellulose.
    [Show full text]
  • The Right to Health in Venezuela
    The Right to Health in Venezuela 154th Period of Sessions of the IACHR Public Hearing - Venezuela Tuesday, March 17th, 2015 Report presented by: PROVEA, Programa Venezolano de Educación-Acción en Derechos Humanos and CODEVIDA, Coalición de Organizaciones por el Derecho a la Salud y a la Vida. NGOs Members of CODEVIDA: Amigos Trasplantados de Venezuela Acción Solidaria en VIH/SIDA Asociación Venezolana de Amigos con Linfoma Asociación Venezolana para la Hemofilia 1 Asociación Civil Senos Ayuda Funcamama, Fundación de Lucha contra el Cáncer de Mama Asociación Venezolana de Drepanocitosis y Talasemias INDEX Page I. General Considerations 4 II. Omission of measures 5 Organic Healthcare Law 5 National Public Health System 5 III. Executive Actions 6 Funding of Public Health 6 Centralization and public funding of private medicine 6 Parallel System Mission Barrio Adentro 7 International Conventions on imports 8 Regulation of prices and private sector imports 8 IV. Health Services 9 Infrastructure 9 Health Personnel 9 Medical-Surgical Supplies 10 Medicines 10 V. Cases of Medical Health Centers 11 Hospital de Niño J.M. de los Ríos (HJMR) 11 2 Maternidad Concepción Palacios (MCP) 12 Hospital Universitario Manuel Núñez Tovar (HUMNT) 12 Hospital Universitario de Caracas (HUC) 13 Banco Municipal de Sangre (BMS) 13 VI. Persons at Risk 14 Persons in need of urgent attention and surgery 14 Pregnant women and newborns 14 Children of age for vaccination 15 Persons in need of dialysis and transplant 15 Persons with hypertension and diabetes 16 Persons with cancer 16 Persons with lymphoma and myeloma 16 Persons with breast cancer 17 Persons with HIV/AIDS 17 Persons with hematologic afflictions 18 Persons with sickle cell anemia and thalassemia 18 Persons with mental health problems 19 Persons living in remote places 19 V.I.
    [Show full text]
  • Artemis Health Tariff.Pdf
    Billing Sr No Procedure Type Codes Procedure Name Price 1 Ambulance Charges EMA001 Ambulance Base Charges(ACLS) 832 2 Ambulance Charges EMA002 Ambulance Rate(ACLS) 44 3 Ambulance Charges EMA003 Ambulance Waiting Time (after 1st hour) 1,556 4 Ambulance Charges EMA004 Doctors Charges Per hour after 2 hours 886 5 Ambulance Charges EMA005 Oxygen 303 6 Ambulance Charges EMA006 Monitor 303 7 Ambulance Charges EMA007 Ventilator 2,344 8 Ambulance Charges EMA008 Porta Vent (ER) 303 9 Ambulance Charges EMA010 TranscutaneousTemporaryCardiacPacing(Am) 1,426 10 Ambulance Charges EMA015 Splinting 1,556 11 Ambulance Charges EMA017 Foley Catheterization 638 12 Ambulance Charges EMA023 ASSISTED MANUAL VENTILATION(AMBULANCE) 918 13 Ambulance Charges EMA025 Consultant Charges Ambulance 1,556 14 Ambulance Charges EMA206 Ryles Tube Insertion 638 15 Ambulance Charges EMA021 Doctors charges (min 2 hrs) 1,394 16 Ambulance Charges EMA100 Ambulance Base Rate(BLS) 638 17 Ambulance Charges EMA101 Ambulance Rate(BLS) 33 18 Anesthesia ANZ112 Unstable patient management 6,264 19 Anesthesia ANZ113 ACT 141 20 Anesthesia ANZ114 FSBS 141 21 Anesthesia ANZ115 Epidural steroid injection 3,564 22 Anesthesia ANZ093 MD Anesthetist for Ambulance (4 hours) 3,564 23 Anesthesia ANZ094 MD Anesthetist for Ambulance (addl hour) 1,556 24 Anesthesia ANZ095 CODE BLUE 3,564 25 Anesthesia ANZ096 Stand by anaesthes for Diagnostics/other 994 26 Anesthesia ANZ098 GA for ECT 3,564 27 Anesthesia ANZ101 Anesthesia visit for emergency managemen 1,556 28 Anesthesia ANZ099 MAC (Sedation) for cath
    [Show full text]
  • The Work of Who 1965
    OFFICIAL RECORDS OF THE WORLD HEALTH ORGANIZATION No. 147 THE WORK OF WHO 1965 ANNUAL REPORT OF THE DIRECTOR- GENERAL TO THE WORLD HEALTH ASSEMBLY AND TO THE UNITED NATIONS I The Financial Report, 1 January -31 December 1965, which constitutes a supplementtothisvolume,is published separately as Official Records No. 150. WORLD HEALTH ORGANIZATION GENEVA March 1966 The following abbreviations are used in the Official Records of the World Health Organization: ACABQ - Advisory Committee on Administrative and Budgetary Questions ACC - Administrative Committee on Co- ordination CIOMS - Council for International Organizations of Medical Sciences ECA - Economic Commission for Africa ECAFE - Economic Commission for Asia and the Far East ECE - Economic Commission for Europe ECLA - Economic Commission for Latin America EPTA - Expanded Programme of Technical Assistance FAO - Food and Agriculture Organization IAEA - International Atomic Energy Agency ICAO - International Civil Aviation Organization ILO - International Labour Organisation (Office) I MCO - Inter- Governmental Maritime Consultative Organization ITU - International Telecommunication Union PAHO - Pan American Health Organization PASB - Pan American Sanitary Bureau TAB - Technical Assistance Board TAC - Technical Assistance Committee UNESCO - United Nations Educational, Scientific and Cultural Organization UNICEF - United Nations Children's Fund UNRWA - United Nations Relief and Works Agency for Palestine Refugees in the Near East UNSCEAR - United Nations Scientific Committee on the Effects of Atomic Radiation WFUNA - World Federation of United Nations Associations WMO - World Meteorological Organization Q World Health Organization 1966 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. Nevertheless governmental agencies or learned and professional societies may reproduce data or excerpts or illustrations from them without requesting an authorization from the World Health Organization.
    [Show full text]